Evidence map›Paper›PMID 29967140›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection.

Megan J Smithey, Vanessa Venturi, Miles P Davenport, Adam S Buntzman, Benjamin G Vincent, Jeffrey A Frelinger, Janko Nikolich-Žugich

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Immune response to COVID-19 in older adults.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Megan J SmitheyDepartment of Immunobiology, University of Arizona College of Medicine, Tucson, AZ 85724.ORCID 0000-0001-8890-3228
Vanessa VenturiInfection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales Australia, Sydney, NSW 2052, Australia.
Miles P DavenportInfection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales Australia, Sydney, NSW 2052, Australia.
Adam S BuntzmanBIO5 Institute, University of Arizona College of Medicine, Tucson, AZ 85721.
Benjamin G VincentLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Jeffrey A FrelingerDepartment of Immunobiology, University of Arizona College of Medicine, Tucson, AZ 85724.ORCID 0000-0002-2503-6267
Janko Nikolich-ŽugichDepartment of Immunobiology, University of Arizona College of Medicine, Tucson, AZ 85724; jnikolich@medadmin.arizona.edu.ORCID 0000-0001-5830-5323
University of Arizona · USUNSW Sydney · AUUniversity of North Carolina at Chapel Hill · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
The Burden of Chikungunya and Dengue Infection in KenyaU54AI081680 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 2009 to 2013
$40.4M
T Cell Homeostasis and Function in Immune SenescenceR01AG020719 · NIA · UNIVERSITY OF ARIZONA · PI NIKOLICH, JANKO Z. · 2001 to 2012
$3.1M
Research Supplement to Impact on CMV Upon T-Cell Aging and Immune DefenseR01AG048021 · NIA · UNIVERSITY OF ARIZONA · PI NIKOLICH, JANKO Z. · 2014 to 2018
$2.6M
NCI NIH HHS P30 CA023074NIAID NIH HHS U54 AI081680NIA NIH HHS R01 AG020719NIA NIH HHS R01 AG048021
6 · The paper itself

Abstract

Lifelong interactions between host and the ubiquitous and persistent cytomegalovirus (CMV) have been proposed to contribute to the age-related decline in immunity. Prior work from us and others found some support for that idea, yet evidence that this led to increased vulnerability to other infections was not obtained. Moreover, evidence has accumulated that CMV infection can be beneficial to immune defense in young/adult mice and humans, dominantly via enhanced innate immunity. Here, we describe an unexpected impact of murine CMV (MCMV) upon the T cell response of old mice to

Indexed as

Immunity, CellularAnimalsCD8-Positive T-LymphocytesCytomegalovirus InfectionsListeria monocytogenesListeriosisMaleMiceMuromegalovirusReceptors, Antigen, T-Cell, alpha-betaReceptors, Antigen, T-Cell, alpha-betaagingCMVimmunitypersistent viruses

Identifiers

PMID29967140
PMCPMC6055168
OpenAlexW2810380358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.